Clinical Advancements And Cloud Integration Will Shape Molecular Diagnostics

AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Published
04 May 25
Updated
24 Jul 25
AnalystConsensusTarget's Fair Value
US$5.50
95.5% undervalued intrinsic discount
24 Jul
US$0.25
Loading
1Y
-75.8%
7D
-4.6%

Author's Valuation

US$5.5

95.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value